The prospective study to evaluate the technical feasibility and clinical effectiveness of endoscopic ultrasounds-guided hepaticogastrotomy with small diameter guide wire.
Not Applicable
Recruiting
- Conditions
- Obstructive jaundice
- Registration Number
- JPRN-UMIN000044441
- Lead Sponsor
- Osaka Medical and Pharmaceutical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1.Cases with serious complications in other organs: 3 or more in ASA classification (excluding dialysis patients) 2.ECOG performance status 4 3.When the prognosis for life is judged to be less than 3 months due to poor general condition 4.Other patients who are judged by the research-responsible (sharing) doctor to be inappropriate as subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method technical success
- Secondary Outcome Measures
Name Time Method early/rate adverse event clinical effect improvement rate stent patency time to stent dysfunction survival rate
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie biliary access success in EUS-guided hepaticogastrotomy for obstructive jaundice?
How does EUS-guided hepaticogastrotomy with small diameter guide wire compare to ERCP in obstructive jaundice outcomes?
Which biomarkers correlate with procedural success in EUS-guided hepaticogastrotomy for biliary obstruction?
What are the adverse event profiles and mitigation strategies for EUS-guided hepaticogastrotomy in jaundiced patients?
What alternative biliary drainage techniques compete with EUS-guided hepaticogastrotomy using small diameter guide wires?